Efficacy and Safety of Fostamatinib in Refractory Immune Thrombocytopenia: A Meta-analysis from Randomized Controlled Trials

Simple item page
dc.contributor.authorSongphol Tungjitviboonkun
dc.contributor.authorNaharuthai Bumrungratanayos
dc.contributor.authorJedsadakorn Jitwimungsanon
dc.contributor.authorThanat Khemakulvanich
dc.date.accessioned2026-05-08T19:23:57Z
dc.date.issued2024-1-1
dc.identifier.doi10.2139/ssrn.4790291
dc.identifier.urihttps://dspace.kmitl.ac.th/handle/123456789/19300
dc.publisherSSRN Electronic Journal
dc.subjectPlatelet Disorders and Treatments
dc.subjectChronic Lymphocytic Leukemia Research
dc.subjectMultiple Myeloma Research and Treatments
dc.titleEfficacy and Safety of Fostamatinib in Refractory Immune Thrombocytopenia: A Meta-analysis from Randomized Controlled Trials
dc.typeArticle

Files

Collections

All